A review of stimuli-responsive nanocarriers for drug and gene delivery.
By S. Ganta, H. Devalapally, Aliasgar F. Shahiwala, M. Amiji. Journal of Controlled Release, 2008
2,027 citations recorded by the source corpus.
Subfields: Biomaterials, Biomedical Engineering, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/aa6f00a678e16d7465c78a83f102061686874f1c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
- J. Hanes
- David R. Kryscio
- Phatsapong Yingchoncharoen
- William B. Liechty
- Ning Gu
- F. Xiong
- Fang Yang
- Nicholas A. Peppas
In Biomedical Engineering
- David R. Kryscio
- Phatsapong Yingchoncharoen
- William B. Liechty
- Nicholas A. Peppas
- T. Georgiou
- D. Richardson
- B. V. Slaughter
- D. Kalinowski
In Molecular Biology
- L. Ensign
- J. Hanes
- David R. Kryscio
- Phatsapong Yingchoncharoen
- William B. Liechty
- Nicholas A. Peppas
- D. Richardson
- B. V. Slaughter
Citations in the corpus
- Thermoresponsive Polymers for Biomedical Applications (2011, background): “In order to overcome these obstacles, drug delivery carriers are being used, most of which are based on polymers [32-34].”
- Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic (2009, background): “Anticancer Drugs 2007;18(10):1189–1200.”
- Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come (2016, methodology): “The manipulation of nanoparticle size and surface charge, as well as the addition of PEG or poly(ethylene oxide), can further help to improve the effectiveness of passive targeting (Ganta et al., 2008).”